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Introduction
The force exerted by the blood on the vasculature is 
known as blood pressure and when this pressure exceeds 
a normal range, a patient becomes hypertensive. By 2030, 
the prevalence of  hypertension is projected to increase by 
7.2% from 2013 estimates by 20301. Hypertension is one of  
the most common cardiovascular diseases and is associated 
with a number of  other conditions, including dyslipidaemia 
and obesity, measured by abnormal body mass index (BMI), 
waist circumference (WC), and waist-hip ratio (WHR)2. 
Although there are increasing efforts by the world’s health 
governing bodies to stem the prevalence of  hypertension 
and its associated risk factors in Africa, the prevalence of  
hypertension still ranges from 6% to more than 48% in 
different rural, semi-urban and urban settlements3–5.
Most African settlements are emerging semi-urban 
settlements and these account for more than half  of  the 
region’s population6. Nigeria is a strategically placed country 
in the West African sub-region, and suffers from a range 
of  non-communicable diseases, including hypertension 
and its modifiable risk factors; indeed, these conditions are 
responsible for at least 20% of  all deaths and constitute 
approximately 60% of  hospital admissions in most tertiary 
health institutions in this country7,8.
The mechanisms of  hypertension in obese individuals were 
poorly understood until recently. Accumulating evidence 
now indicates a close interaction between visceral adipose 
tissue and dysfunctional neurohormonal mechanisms, 
including adiponectin, leptin, resistin, tumour necrotic factor 
(TNF), and interleukin (IL)-6 caused by increased adiposity 
(fat deposition)9–11. An increase in cardiac output without 
a corresponding reduction in systemic vascular resistance, 
which is characteristic of  obesity, also probably contributes 
to the aetiology of  the hypertension in obesity. On the 
other hand, the association between dyslipidaemia and 
hypertension has been referred to recently as ‘lipitension’, 
a condition that is primarily caused by endothelial damage 
and the loss of  physiological vasomotor activity due to 
atherosclerosis which usually occurs concomitantly with 
dyslipidaemia12. Dyslipidaemia refers to abnormal levels in a 
patient’s lipid profile while obesity is determined by abnormal 
BMI, WC or WHR. Several studies have reported that obesity 
and dyslipidaemia often occur simultaneously and it is not 
uncommon for these conditions to co-exist in an individual. 
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This study aimed to determine the relationship between measures of  obesity and serum lipid levels among hypertensive patients.
Methods
This was a cross-sectional study in which participants newly diagnosed with hypertension formed the study population. A range of  
demographic and anthropometric data was obtained, including weight, height, and waist and hip circumference. Fasting serum lipids 
were also measured, including total cholesterol, high density lipoprotein cholesterol (HDL-C) and triglycerides (TG). Low density 
lipoprotein cholesterol (LDL-C) was calculated using Friedewald formula. Statistical analysis was then carried out to determine the 
relationship between anthropometric indices and lipid profile levels. 
Results
The study population consisted of  124 male and 290 female subjects with a mean age of  66±16.95 years (range, 30–100 years).
The female subjects were older than the male subjects (p=0.020). Our analysis showed that 85%, 58.5% and 30.7% of  the study 
population had abnormal waist circumference (WC), abnormal waist-hip ratio (WHR) and a body mass index (BMI) >25 kg/m2, 
respectively. Decreased HDL-C (70.1%) was the commonest lipid abnormality detected, followed by elevated LDL (6.0%). None 
of  the anthropometric indices were independent predictors of  abnormal lipid levels. However, advanced age and female sex were 
independent predictors for at least one serum lipid abnormality.
Conclusion
None of  the measures of  obesity could independently predict abnormal lipid levels in individuals newly diagnosed with hypertension. 
However, female sex, advanced age and systolic blood pressure were independently associated with abnormal serum lipids. Encouraging 
regular exercise, and the possible addition of  statins, may be beneficial in addressing both obesity and dyslipidaemia.
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These studies are with contrasting results. However, very 
few studies have been carried out in Nigeria to predict which 
measure of  obesity (if  any) will predict different types of  
lipid abnormality.Therefore, the purpose of  this study was 
to evaluate the association between measures of  obesity 
(abnormal BMI, WC and WHR) and dyslipidaemia in 
individuals newly diagnosed with hypertension, living in a 
semi-urban community in Nigeria. 
Materials and methods
This was a cross sectional study of  dyslipidaemia and obesity 
in individuals newly diagnosed with hypertension, living 
in semi-urban communities located in Ekiti State, Nigeria. 
The subjects were aged ≥30 years and the study was carried 
out between January and May, 2013. The sample was a 
subset of  a larger sample in a study for the determination 
of  cardiovascular assessment in semi-urban communities5. 
The subjects were asked basic questions about their age and 
other sociodemographic data. The instrument used was the 
WHO STEPS (II) questionnaire13. Clinical evaluation, along 
with blood and urine sample collection, were carried out 
at designated places in the communities such as churches, 
mosques, town halls, health centres and other convenient 
places. 
Anthropometric and blood pressure measurements
Height: This was measured using a portable stadiometer. The 
subjects were asked to stand barefoot, place their arms by 
their sides and lean back on a vertical board14. Their height 
was then recorded to the nearest 0.1 cm.
Weight: This was taken while in light clothing with the 
subject standing in the centre of  the platform of  a standard 
portable bathroom weighing scale; weight was recorded to 
the nearest 0.1 kg
Waist circumference: The subject was asked to stand 
comfortably with their feet 25–30 cm apart. Measurements 
were then taken with a tape measure at a point midway 
between the inferior margin of  the lower-most rib and the 
iliac crest in a horizontal plane14. The waist circumference 
was measured to the nearest 0.1 cm at the end of  normal 
expiration.
Hip circumference: Measurements were taken using a tape 
measure and was measured with the greater trochanters of  
the femur as reference points. The measurement was to the 
nearest 0.1 cm.
Blood pressure: Blood pressure (BP) was measured 
according to the guidelines presented in the seventh report 
of  the Joint National Committee on Prevention, Detection, 
Evaluation and Treatment of  High Blood Pressure (JNC-7)15. 
Systolic blood pressure (SBP) and diastolic blood pressure 
(DBP) were measured in the left arm after the participant 
had been seated for at least 5 minutes. An electronic blood 
pressure monitor (Omron M X2 Basic, Omron Health 
Care Co. Limited, Kyoto, Japan), which had been validated 
by the British Hypertension Society, was then used with an 
appropriate-sized cuff. The length and width of  the blood 
pressure cuff  bladder were approximately 80% and at least 
40% of  the circumference of  the upper arm, respectively. 
BP was taken twice and if  the difference was more than 10 
mmHg, a third reading was taken at an interval of  about 5 
minutes.
Laboratory tests
Three millilitres of  blood samples were collected after 8–12 
hours of  overnight fasting from each patient into plain bottles 
for lipid profile analysis, including total cholesterol (TC), high 
density lipoprotein cholesterol (HDL-C), and triglycerides 
(TG). However, low density lipoprotein cholesterol (LDL-C) 
was calculated using Frieeward’s equation16. The samples 
were stored in a freezer at −8°C to await batch analysis in 
the laboratory. 
Definition of terms
Hypertension: Hypertension was defined as  SBP>140 
mmHg and/or DBP≥90 mmHg and/or the concomitant 
use of  antihypertensive medications15.
Dyslipidaemia: Dyslipidaemia was defined according to the 
Adult Treatment Panel III17 as raised TG level ≥1.7mmol/L, 
reduced HDL-cholesterol <1.03 mmol/L in males and <1.30 
mmol/L in females, LDL-C level >3.37 mmol/L and/or TC 
level ≥5.2 mmol/L. 
Obesity: Abnormal WC, WHR and BMI were defined as ≥94 
cm in men and ≥80 cm in women; >0.90 for men and >0.85 
for women; and ≥25 kg/m2 across sexes, respectively17.
Ethical considerations
Prior notices and permissions were obtained from traditional 
rulers, opinion leaders, church and mosque leaders. Informed 
consent was obtained from all participants. Ethical clearance 
was obtained from the ethics and research committee of  
Federal Medical Centre, Ido-Ekiti.
Statistical analysis
All the data were recorded and analysed using the Statistical 
Package for Social Sciences software (SPSS Inc, Chicago, IL; 
version 17). Continuous variables, including age, SBP, DBP, 
lipid profile, BMI, WC, and WHR, are presented as mean 
± standard deviation and compared between sexes while 
other categorical variables were expressed in frequencies 
and percentages. A p-value <0.05 was considered to indicate 
statistical significance. Pearson correlation was used to 
test for association between measures of  obesity and lipid 
abnormalities. Logistic regression models were constructed 
using the presence of  at least one lipid abnormality (abnormal 
TC, LDL-C, HDL-C and TG) as the dependent variables, 
and age, sex, blood pressure and indices of  body adiposity as 
the independent variables.
Results
A total of  124 male and 290 female Nigerian hypertensive 
patients were included in this study with age ranging from 30 
to 100 years (mean=66.00±16.95 years). The female subjects 
were older than the male subjects (67.18±14.40 years vs. 
63.22±18.89 years; p=0.020). There were also significant sex 
differences in WC, LDL-C and TG (Table 1)
Table 1: Basic demographic and clinical data of  the population 
(mean ± standard deviation)
Variable Male Female p–Value
Age (years) 63.22 ± 18.89 67.18 ± 14.40 0.020
Weight (kg) 61.69 ± 14.10 57.09 ± 12.55 0.004
Height (m) 1.62 ± 0.14 1.55 ± 0.07 <0.001
BMI(kg/m2) 22.49 ± 3.40 23.44 ± 4.86 0.050
WC (cm) 84.82 ± 9.73 88.03 ± 12.42 0.011
WHR 0.94 ± 0.06 0.96 ± 0.58 0.712
SBP (mmHg) 159.56 ± 25.99 161.36 ± 23.83 0.492
DBP (mmHg) 89.31 ± 13.58 89.70 ± 12.74 0.783
TC (mmol/L) 3.05 ± 0.97 3.22 ± 1.17 0.137
HDL–C (mmol/L) 1.12 ± 0.53 1.02 ± 0.49 0.067
LDL–C (mmol/L) 1.61 ± 0.86 1.83 ± 0.99 0.030
TG (mmol/L) 0.74 ± 0.34 0.85 ± 0.56 0.036
BMI = Body Mass Index, WC = Waist circumference, WHR = Waist – Hip ratio, 
SBP = Systolic Blood Pressure, DBP = Diastolic Blood Pressure, TC = Total 
Cholesterol, HDL–C = High density lipoprotein–Cholesterol, LDL–C = Low 
density lipoprotein–Cholesterol, TG = Triglycerides
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Table 3: Relationships between serum lipids, age, sex and blood 
pressure 
There was no significant relationship between the measures 
of  obesity (WC, WHR and BMI) and any of  the lipid sub-
fractions (Table 4). Pearson’s correlation found that there 
were no associations between these measures (Table 5).
Table 4: Relationships between serum lipids and measures of 
obesity
Among the subjects, a disproportionately higher number 
of  females had abnormal measures for both obesity and 
dyslipidaemia. A total of  218 females (75.2%) had abnormal 
WC as compared to 24 (19.4%) of  the males. More than 
30% of  the study population had a BMI >25 kg/m2. In 85% 
of  cases, WHR was abnormal. Lipid sub-fraction analysis 
showed that low HDL-C was the most common abnormality 
and was observed in 70.0% of  the study population, followed 
by elevated LDL-C levels, observed in 6.0% of  the study 
population (Table 2). Of  the dyslipidaemias, 6.6%, 75.9%, 
7.6% and 5.9% of  the females had high TC, low HDL, high 
LDL and high TG, respectively. Of  these, only low HDL 
and high LDL were significantly higher than that of  males 
(p<0.001, p=0.030, respectively). 
Table 2: Prevalence of  obesity and dyslipidaemia in the study 
population according to sex
Figure 1 shows the prevalence of  the various lipid 
abnormalities. Among the participants, 310 (74.9%) had 
at least one form of  lipid abnormality. More than a tenth 
(12.9%) of  those with dyslipidaemia had more than one 
lipid abnormality in various combinations. Elevated TG and 
low HDL-C (14, 4.5%) was the most frequent dyslipidaemia 
combination, followed by the combination of  elevated TC 
and elevated LDL-C (11, 3.5%).
Figure 1: (A) Venn diagram showing the frequencies of, and 
overlap between, abnormal total cholesterol, HDL, LDL and 
triglycerides among subjects. (B) Representation of abnormal 
HDL and LDL profiles. (C) Representation of TC and TG. (D) 
Representation of subjects with no abnormalities in serum lipid 
profiles
The relationship between serum lipids, age, sex and blood 
pressure is shown in Table 3. SBP was significantly higher 
in subjects with abnormal TC when compared with subjects 
with normal TC (171.7±27.8 vs. 160.2±24.2; p=0.029). 
Furthermore, when compared between sexes, females 
had a significantly higher LDL-C and lower HDL-C when 
compared with males, 22 (7.6%) vs. 3 (2.4%); p=0.043 and 
220 (75.9%) vs. 70 (56.5%); p<0.001).
Variable Total n=414 Male n=124(%) Female n=290(%) p–value
Abnormal WC 242 (58.5) 24 (19.4) 218 (75.2)
<0.001
Abnormal BMI 127 (30.7) 29 (23.4) 98 (33.8)
0.022
Abnormal WHR 352 (85.0) 93 (75.6) 259 (89.3)
<0.001
High TC 23 (5.6) 4 (3.2) 19 (6.6)
0.130
Low HDL 290 (70.0) 70 (56.5) 220 (75.9)
<0.001
High LDL 25 (6.0) 3 (2.4) 22 (7.6)
0.030









Normal 65.8±16.2 120 (96.8) 271 (93.4) 160.2±24.2 89.5±12.9
Abnormal 69.6±11.2 4 (3.2) 19 (6.6) 171.7±27.8 91.5±14.8




121 (97.6) 268 (92.4) 160.5±24.2 89.5±13.1
Abnormal
68.1±13.8







54 (43.5) 70 (24.1) 158.7±24.5 88.2±12.7
Abnormal
67.2±14.8
70 (56.5) 220 (75.9) 161.7±24.5 90.2±13.1
p 0.028 <0.001 0.255 0.124
TG
Normal 65.8±16.1 121 (97.6) 273 (94.1) 161.0±26.8 89.6±12.8
Abnormal 69.6±12.4 3 (2.4) 17 (5.9) 160.8±26.8 89.6±16.0
p 0.301 0.135 0.981 0.987
At least 1 lipid 
abnormality
Normal 61.9±18.7 49 (39.5) 55 (60.5) 157.2±23.7 87.8±12.0
Abnormal 67.4±14.7 75 (19.0) 235 (81.0) 162.1±24.7 90.2±13.3
p 0.008 0.000 0.078 0.105
WC n (%) WHR n (%) BMI n (%)
Normal Abnormal
Normal Abnormal Normal Abnormal
TC
Normal 
165 (95.9) 226 (93.4)
60 (98.4) 330 (93.8) 270 (94.1) 121 (95.3)
Abnormal
7 (4.1) 16 (6.6)
1 (1.6) 22 (6.2) 17 (5.9) 6 (4.7)
p 0.266 0.147 0.623
LDL-C
Normal 165 (95.9) 224 (92.6)
60 (98.4) 328 (93.2) 269 (93.7) 120 (94.5)
Abnormal 7 (4.1) 18 (7.4)




Normal 60 (34.9) 64 (26.4) 22 (36.1) 102 (29.0) 84 (29.3) 40 (31.5)




Normal 166 (96.5) 228 (94.2)
60 (98.4) 333 (94.6) 275 (95.8) 119 (93.7)
Abnormal 6 (3.5) 14 (5.8)
1 (1.6) 19 (5.4) 12 (4.2) 8 (6.3)
p 0.283 0.207
0.354
At least 1 lipid 
abnormality
Normal 52 (30.2) 52 (21.5) 21 (34.4) 83 (23.6) 70 (24.4) 34 (26.8)
Abnormal
120 (69.8) 190 (78.5) 40 (65.6) 269 (76.4) 217 (75.6) 93 (73.2)
p
0.043 0.072 0.606
BMI = Body Mass Index, WC = Waist circumference, WHR = Waist – Hip 
ratio, TC = Total Cholesterol, HDL–C = High density lipoprotein–Cholesterol, 
LDL–C = Low density lipoprotein–Cholesterol, TG = Triglycerides
p = p-value, (m ± sd) = mean ± standard deviation, SDP = systolic blood 
pressure, DBP = diastolic blood pressure, TC = total cholesterol, LDL = low 
density lipoprotein cholesterol, HDL = high density lipoprotein cholesterol, TG 
WC = Waist circumference, WHR = Waist – Hip ratio, BMI = Body Mass 
Index, TC = Total Cholesterol, HDL–C = High density lipoprotein–Cholesterol, 
LDL–C = Low density lipoprotein–Cholesterol, TG = Triglycerides, p = p-value
Variables WC WHR BMI Age SBP DBP
TC          r 













HDL-C    r 













LDL-C    r 













TG         r 













BMI = Body Mass Index, WC = Waist circumference, WHR = Waist – Hip ratio, TC = 
Total Cholesterol, HDL–C = High density lipoprotein–Cholesterol, LDL–C = Low density 
lipoprotein–Cholesterol, TG = Triglycerides.
Table 5: Correlation matrix of measures obesity and serum 
lipids among the subjects
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risks, though not fully elucidated, has been shown to relate 
to its potent anti-inflammatory and anti-oxidant effect that 
inhibits the atherogenic process24,25.
Our study showed that none of  the commonly used 
anthropometric indices were good enough to predict an 
abnormal lipid profile. However, we did identify a significant 
association with DBP, with WC having more association 
(p=0.001) than WHR (p=0.035), in a sample of  semi-urban 
dwellers in south-western Nigeria. A similar finding was 
observed by Okpara and AAdediran26 who found abnormal 
lipids to be strongly associated with both SBP and DBP. 
The significant association between WC and WHR with 
DBP is consistent with the established evidence that a direct 
association exists between obesity and blood pressure27. There 
was no significant alteration in lipid profiles with obesity 
among participants, which implies that obesity may be a 
less important factor in predicting abnormal lipid profiles in 
this population. This finding concurs with previous reports 
reporting a lack of  association between lipid abnormalities 
and measures of  obesity26, but contradicts some studies 
which have shown a positive association between lipid levels 
and adiposity23,28.
To our knowledge, this is the first study to compare 
three commonly used anthropometric indices to predict 
dyslipidaemia among patients with hypertension in a 
population of  semi-urban dwellers of  Nigeria. Our focus was 
to compare various indices of  obesity among hypertensive 
patients in terms of  their ability to predict dyslipidaemia.
The strength of  the study was based on the fact that it 
was a community-based study with a moderate number of  
participants. However, the cross-sectional design of  this 
study limits the freedom with which its results regarding 
causal relationships can be interpreted. Hence, prospective 
longitudinal studies should now be carried out, with larger 
sample sizes. Finally, we did not calculate novel lipid ratios 
like the Atherogenic Index of  Plasma (AIP), Castelli Risk 
Index (CRI) I & II and Chol Index, which may also be 
abnormal, even in the presence of  abnormal, but not 
statistically significant, lipid levels.
Conclusion 
The findings of  this study suggest that obesity is significantly 
more prevalent among female sub-urban dwellers with 
hypertension compared with their male counterparts and is 
not an important predictor of  abnormal serum lipid levels. 
Advanced age, female sex and higher SBP were the most 
important and independent predictors of  abnormal lipid 
levels in this population with hypertension. Also, there was 
positive correlation between WC and WHR and DBP.
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